Amneal Pharmaceuticals
AMRX
AMRX
164 hedge funds and large institutions have $1.55B invested in Amneal Pharmaceuticals in 2019 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 60 increasing their positions, 50 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
2% less funds holding
Funds holding: 168 → 164 (-4)
6.69% less ownership
Funds ownership: 101.07% → 94.38% (-6.7%)
14% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 21
Holders
164
Holding in Top 10
1
Calls
$1.31M
Puts
$213K
Top Buyers
| 1 | +$6.15M | |
| 2 | +$5.79M | |
| 3 | +$5.33M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$3.4M |
| 5 |
Squarepoint
New York
|
+$3.06M |
Top Sellers
| 1 | -$31.8M | |
| 2 | -$28.7M | |
| 3 | -$23.4M | |
| 4 |
BM
Bridger Management
New York
|
-$13.8M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$10.7M |